Stay updated on TERN-201 Safety and Efficacy in NASH Clinical Trial

Sign up to get notified when there's something new on the TERN-201 Safety and Efficacy in NASH Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TERN-201 Safety and Efficacy in NASH Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    NAFLD is added as a related topic and explicit state locations (Arizona, California, Louisiana, Texas) are now listed under Locations. The HHS Vulnerability Disclosure link and the prior state location listings were removed, and the revision is updated to v3.3.3.
    Difference
    0.7%
    Check dated 2025-12-23T21:27:12.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Non-alcoholic fatty liver disease and related topics (MedlinePlus Genetics) were removed from the page, reducing contextual information and navigation options for readers interested in NAFLD/NASH.
    Difference
    0.2%
    Check dated 2025-12-16T20:48:42.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Related topic links for Non-alcoholic fatty liver disease and MedlinePlus Genetics were added, without affecting core study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-02T16:47:12.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.3.2 added; removal of 'Non-alcoholic fatty liver disease' keyword and 'MedlinePlus Genetics' related topic; removal of 'Revision: v3.2.0'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-25T11:16:09.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The page no longer displays the government funding operating status notice that informed users about potential delays and the NIH Clinical Center's operating status. This change does not affect the study details, enrollment criteria, or outcome information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:00:59.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    Added related topics: Non-alcoholic fatty liver disease under MedlinePlus Genetics, and Fatty Liver Disease as related topics. The update appears in the related topics section and does not modify core trial details, eligibility, or results.
    Difference
    0.6%
    Check dated 2025-11-03T21:07:28.000Z thumbnail image

Stay in the know with updates to TERN-201 Safety and Efficacy in NASH Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TERN-201 Safety and Efficacy in NASH Clinical Trial page.